Home » Topics » BioWorld Science

BioWorld Science
RSS

University of Texas System identifies CBP and/or p300 inhibitors

April 28, 2022

Humanwell Healthcare presents new P2X3 receptor antagonists

April 28, 2022

New YAP1/TEAD interaction inhibitors disclosed by SpringWorks Therapeutics and collaborators

April 28, 2022

Chinese researchers divulge new compounds for cancer

April 28, 2022

BLU-222 shows efficacy in CCNE1-amplified ovarian cancer models

April 28, 2022

KSHN-001034, a novel prodrug that delivers higher fulvestrant concentrations

April 28, 2022

Nektar Therapeutics presents preclinical data on NKTR-255

April 28, 2022

WVE-004 shows promise for treating C9orf72-associated neurologic disorders

April 27, 2022

CIDRAP receives funding to create coronavirus vaccines R&D roadmap

April 27, 2022

PharmAbcine reports GLP toxicology results for TIE2-activating antibody PMC-403

April 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...